DLHL
NBP

Donald L. Hagan LLC’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Donald L. Hagan LLC’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,000
Closed -$50.1K – 100
2024
Q2 		$50.1K Hold
30,000
– – 0.03% 92
2024
Q1 		$55.8K Hold
30,000
– – 0.03% 101
2023
Q4 		$57K Buy
+30,000
New +$44.8K 0.03% 99

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EPL
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Donald L. Hagan LLC's NBP Position: Q3 2024 in Review

Donald L. Hagan LLC sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2024, closing a stake of 30,000 shares — an estimated $50.1K sold.

Donald L. Hagan LLC first reported a position in NBP in Q4 2023 and held it in 3 quarters. The position peaked at $57K in Q4 2023. 28 funds tracked by Wall St. Rank hold NBP as of Q3 2024.

  • Donald L. Hagan LLC reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Donald L. Hagan LLC sold 30,000 NovaBridge Biosciences American Depositary Shares shares in Q3 2024, an estimated $50.1K.
  • Donald L. Hagan LLC first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2023 and held it in 3 quarters.
  • Donald L. Hagan LLC's NovaBridge Biosciences American Depositary Shares position peaked at $57K in Q4 2023.
  • 28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2024.

Based on Donald L. Hagan LLC's 13F filing for Q3 2024, filed 30 Oct 2024.